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Abstract 
Nitrate-rich beetroot juice (BRJ) increases plasma nitrite concentration, lowers the oxygen cost 
(V̇O2) of steady-state exercise and improves exercise performance in sedentary and 
moderately-trained, but rarely in well-trained individuals exercising at sea-level. BRJ 
supplementation may be more effective in a hypoxic environment, where the reduction of 
nitrite into nitric oxide (NO) is potentiated, such that well-trained and less well-trained 
individuals may derive a similar ergogenic effect.   We conducted a randomised, 
counterbalanced, double-blind placebo controlled trial to determine the effects of BRJ on 
treadmill running performance in moderate normobaric hypoxia (equivalent to 2500 m altitude) 
in participants with a range of aerobic fitness levels. Twelve healthy males (V̇O2max ranging 
from 47.1 - 76.8 ml·kg-1·min-1) ingested 138 ml concentrated BRJ (~ 15.2 mmol nitrate) or a 
nitrate-deplete placebo (PLA) (~ 0.2 mmol nitrate).  Three hours later, participants completed 
steady-state moderate intensity running, and a 1500 m time-trial (TT) in a normobaric hypoxic 
chamber (FIO2 ~15 %).  Plasma nitrite concentration was significantly greater following BRJ 
versus PLA 1 hour post supplementation, and remained higher in BRJ throughout the testing 
session (p < 0.01). Average V̇O2 was significantly lower (BRJ: 18.4 ± 2.0, PLA: 20.4 ± 12.6 
ml·kg-1·min-1; p = 0.002), whilst arterial oxygen saturation (SaO2) was significantly greater 
(BRJ: 88.4 ± 2.7, PLA: 86.5 ± 3.3 %; p < 0.001) following BRJ.  BRJ improved TT 
performance in all 12 participants by an average of 3.2 % (BRJ: 331.1 ± 45.3 vs. PL: 341.9 ± 
46.1 s; p < 0.001). There was no apparent relationship between aerobic fitness and the 
improvement in performance following BRJ (r2 = 0.05, p > 0.05). These findings suggests that 
a high nitrate dose in the form of a BRJ supplement may improve running performance in 
individuals with a range of aerobic fitness levels conducting moderate and high-intensity 
exercise in a normobaric hypoxic environment. 
 
 
 
Key words: Nitric Oxide, Nitrate, Exercise performance, Hypoxia 
  
3 
 
1. Introduction 
Supplementation with dietary nitrate via nitrate-rich foods or nitrate salts elicits an array of 
potentially beneficial physiological changes.  These include, but are not restricted to: lower 
blood pressure [1–3], reduced O2 consumption (V̇O2) during steady-state exercise [4–6], 
attenuated muscle metabolic perturbations [7,8], and enhanced muscle force production [9,10]. 
These effects are not directly attributable to the nitrate anion, which is relatively inert [11].  
Instead, the benefits of nitrate supplementation appear to be related to an increased production 
of the multifunctional signalling molecule nitric oxide (NO).  Ingested nitrate is reduced to 
nitrite by symbiotic bacteria residing predominantly on the dorsal surface of the tongue [12,13]. 
A portion of the nitrite is converted into NO in the acidic environment of the stomach [14,15], 
but the majority enters systemic circulation where it may be reduced to NO and other bioactive 
nitrogen oxides in the blood and tissue via various nitrite reductases [11].   
 
Increasing NO bioavailability via nitrate supplementation has been reported to improve 
exercise time to exhaustion (TTE) or time-trial (TT) performance in the majority [5,16–18], 
but not all [23,24] previous investigations in untrained and moderately-trained individuals. 
Conversely, well-trained participants (V̇O2max > 60 ml·kg-1·min-1) are typically less responsive 
to dietary nitrate supplementation [17,19–21,25–27], even when very high nitrate doses (~ 19.5 
mmol) are administered [28].  Highly-trained individuals are known to possess elevated 
baseline nitrate/ nitrite reserves [29], may habitually consume large amounts of nitrate, 
subsequent to their increased calorie consumption [30], and exhibit greater presence and 
activity of the NOS enzymes, relative to the untrained [31].  Such differences may reasonably 
be expected to lessen the ergogenic effect of nitrate supplementation [30].   
 
The reduction of nitrite to NO, and hence the capacity to influence NO mediated physiological 
processes, is potentiated when muscle pH [32] and PO2 [33] decline.  Conversely, the L-
arginine NOS pathway becomes dysfunctional with low O2 tensions and pH [33].  Such cellular 
conditions are likely to be especially prevalent during exercise in a hypoxic environment [8,34], 
such as experienced on ascent to terrestrial altitude.  This suggests that nitrate supplementation 
may be more likely to enhance NO generation and therefore improve performance in hypoxia 
relative to normoxia.  Moreover, an improvement in mitochondrial [35] and/ or muscle 
contractile efficiency [7] subsequent to nitrate supplementation which reduces V̇O2 is likely to 
be especially advantageous when O2 availability is low.  This is supported by the findings of a 
recent study, in which nitrate supplementation improved tolerance to severe intensity cycling 
in hypoxia (FIO2 13.1 %) but not normoxia [36].  However, in other studies, nitrate 
supplementation has been shown both to improve [8,22,37] and have no effect [38–40] on 
hypoxic exercise performance.  These equivocal findings may be attributed to differences in 
the training status of participants, exercise protocol, supplementation protocol, and hypoxic 
stimuli applied, and warrant further exploration.   
 
Evidence from murine models suggests that the effects of dietary nitrate supplementation may 
be fibre type specific, increasing muscle perfusion and oxygenation [41,42], and enhancing 
calcium handling and force production [9] in type II muscle fibres only, as may be recruited 
during high-intensity exercise (for review, see Jones et al. [43]). Moreover, nitrate 
supplementation has been demonstrated to elicit beneficial effects when the contribution of 
type II muscle towards force generation is high, including at fast but not slow muscle 
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contraction frequencies [44], and during the transition from moderate to severe but not 
unloaded to moderate intensity exercise [45].   
 
It is possible that nitrate supplementation is especially effective when conducting high-
intensity exercise in a hypoxic environment, such that individuals across a range of aerobic 
fitness levels may derive a similar performance enhancing benefit from dietary nitrate 
supplementation.  This has considerable relevance, given the widespread popularity of travel 
to high-altitude (i.e. hypobaric hypoxia) each year for recreational (e.g. hiking, skiing, 
mountaineering) and sporting (e.g. training camps, high-altitude running events, and cycle 
mountain stages) purposes in individuals with a range of different fitness levels.  Therefore, 
the purpose of this study was to assess the effect of nitrate supplementation on physiological 
functioning and TT performance in moderate normobaric hypoxia (equivalent to 2500 m) in 
individuals with varying aerobic fitness levels (VO2max).  We hypothesised that: (1) dietary 
nitrate supplementation would enhance exercise performance in hypoxia and (2) this effect 
would be consistent across a range of aerobic fitness levels.  
 
2. Methods 
2.1 Participants 
Twelve healthy men aged 24.4 ± 4.3 years, with a body mass of  76.4 ± 9.6 kg, stature of 181.6 
± 6.4 cm, and maximal O2 uptake (V̇O2max) at sea-level (normoxia) of 62.1 ± 9.3 ml·kg-1·min-
1 (range: 47.1 to 76.8 ml·kg-1·min-1) and simulated altitude (2500 m) of 52.2 ± 7.5 ml·kg-1·min-
1 (range: 40.8 to 61.8 ml·kg-1·min-1) volunteered to take part in this study.  Participants were 
recruited across a range of aerobic fitness levels to assess the relationship between V̇O2max and 
the change in hypoxic exercise performance consequent to nitrate supplementation. The 
participant cohort comprised six competitive runners / triathletes (all with experience racing 
over 1500 m), four individuals who regularly took part in recreational sport but were not 
competitive athletes, and two individuals who were physically active, yet did not take part in 
any sport.  The study received institutional ethical approval and was conducted in accordance 
with the Declaration of Helsinki. Participants provided written informed consent prior to 
testing.  
 
2.2 Overview 
Participants visited the laboratory on five occasions within a six week period. On the first visit 
to the laboratory, participants completed an incremental running test to volitional exhaustion 
in normoxia to determine V̇O2max. The values obtained were used to define training status.   
Each subsequent session involved exercise in a normobaric hypoxic chamber (TISS, Alton, 
UK, and Sporting Edge, Sherfield on Loddon, UK) situated at ~ 113 m above sea-level at a 
simulated altitude of 2500 m (FIO2 ~ 15.0 %).  FIO2 was adjusted daily based around 
fluctuations in barometric pressure, and accounting for 47 mmHg water vapour pressure [46].  
Ambient air temperature and relative humidity were maintained at 20 °C and 50 % respectively.   
On the second visit to the laboratory, participants completed an incremental running test in 
hypoxia, to define altitude specific V̇O2max, and elucidate suitable relative exercise intensities 
for the experimental trials. The third visit involved a familiarisation session, replicating the 
experimental trials but without any intervention. The fourth and fifth visits constituted the 
experimental trials.  Experimental trials were preceded by the consumption of 138 ml 
concentrated nitrate-rich (BRJ) (~ 15.2 mmol nitrate) or nitrate-deplete (PLA) (~ 0.2 mmol 
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nitrate) beetroot juice (BEET IT, James White Drinks Ltd., Ipswich, UK), administered in a 
randomised double-blind cross-over design three hours before exercise.  Participants were 
asked to abstain from intense exercise, alcohol, and caffeine for 24 hours prior to each trial. 
Antibacterial mouthwash and chewing gum, known to ablate the oral bacteria responsible for 
nitrate reduction into nitrite, was also avoided [47].    
 
2.3. Preliminary trials 
A two-part incremental running test was conducted on a motorised treadmill (Woodway, 
Cranlea, Birmingham, UK) [48], once in normoxia and once in normobaric hypoxia. 
Participants completed five to eight sub-maximal stages lasting three minutes, separated with 
one minute recovery periods. Starting speed was determined based around perceived 
participant fitness.  Running speed was increased by 1 km·h-1 each stage, and a 1 % treadmill 
gradient was applied to approximate the energetic cost of outdoor running [49].  Finger-tip 
blood samples were obtained between stages to determine blood lactate concentration (YSI 
2300 STAT plus, Yellow Springs, Ohio).  Exercise was ceased when blood lactate 
concentration reached 4 mM.   The second phase of the test commenced following 5 minutes 
recovery.  A fixed running speed equal to the final speed obtained during the first part of the 
test, minus 2 km·h-1 was applied. The gradient was increased by 1 % every minute, until 
volitional exhaustion. Respiratory variables were monitored continuously via an online gas 
analysis system, calibrated before each trial according to the manufacturer’s instructions 
(MedGraphics Ultima CPX, MGC Diagnostics, MN, USA).  
 
2.4. Experimental trials 
2.4.1. Protocol 
On the morning of each experimental session, participants arrived at the laboratory between 7 
and 9 am following an overnight fast. A cannula was fitted by a trained phlebotomist into a 
vein in the arm to enable repeated blood sampling.  Participants then ingested BRJ or PLA 
within a 5 minute period and consumed a standardised breakfast (360 kcal, carbohydrates 62 
%, fat 22 %, protein 16 %) within a 10 minute period.  They then rested in normoxia for 2.5 
hours, during which time water was permitted ad libitum.  Participants then entered the hypoxic 
chamber, where they rested for a further 30 minutes.  Exercise commenced 3 hours post-
supplementation, and included 2 x 15 minute bouts of steady-state running at 45 % and 65 % 
altitude-specific V̇O2max, each followed by a 5 minute recover period.  A 1500 m TT then 
commenced.  Participants ran at a speed approximating 80 % altitude-specific V̇O2max for 30 
seconds as a ‘rolling start’, before the TT commenced. Participants were asked to run the 1500 
m TT as fast as possible. Running speed and time were not visible during the TT, although 
participants were informed of the distance they had covered at 200 m intervals.  The treadmill 
gradient was set to 1 % throughout exercise [49].  We have previously demonstrated excellent 
reliability of this performance test (CV < 1 %)[50].  Participants rested in normobaric hypoxia 
for 10 minutes following TT, after which they were free to leave.   
 
2.4.2. Measurements 
Ten blood samples were drawn throughout each experimental trial, comprising two, 4 ml 
lithium heparin containing vacutainers (Becton Dickinson, Plymouth, UK) for later 
determination of plasma nitrate and nitrite.  Measurement points included pre-supplementation, 
30, 60, 90, 120, 150 (pre-hypoxic exposure), and 180 (pre-exercise) minutes post-
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supplementation, following each bout of steady-state exercise, and immediately post-TT.  
Blood pressure (BP) of the brachial artery was measured using an automated 
sphygmomanometer (Omron Healthcare Ltd., Kyoto, Japan) pre-supplementation, pre-hypoxic 
exposure, pre-exercise, and 5 minutes post-TT.  Mean arterial pressure (MAP) was calculated 
as 1/3·systolic pressure + 2/3·diastolic pressure [51].  At the same time points, a measure of 
exhaled NO was also recorded, using a hand-held electrochemical analyser (NObreath, Bedfont 
Scientific Ltd., UK).  Four measures were obtained for BP and exhaled NO, and the mean value 
of the final three measurements was used for data analysis.  Heart rate (HR) was measured via 
a chest worn heart-rate monitor strap (Polar Electro, Oy, Finland) pre-supplementation, pre-
hypoxic exposure, pre-exercise, during the final 2 minutes of each steady-state exercise bout, 
and immediately post-TT.  Arterial O2 saturation (SaO2) was monitored via pulse oximetery 
(Nellcor, Medtronic, Minneapolis, MN) pre-hypoxic exposure, pre-exercise, during the final 2 
minutes of each steady-state exercise bout, and immediately post-TT.  Expired gas was 
monitored as previously described for 10 minutes pre-exercise, and during steady-state 
exercise.  Data obtained during the final 5 minutes of rest and each steady-state exercise bout 
was averaged and used for subsequent analysis.   Perceptions of exertion were also monitored 
during the final 2 minutes of each steady-state exercise bout and immediately post-TT using a 
15 point (6 – 20) ratings of perceived exertion (RPE) scale [52]. 
 
2.5. Assessment of NO blood metabolites 
2.5.1. Blood handling 
Blood samples were centrifuged at 5000 rpm for 3 minutes immediately post-collection.  
Plasma (1 ml) was drawn from each vacutainer into opaque cryotubes (Argos Technologies, 
IL, USA), each containing 6.5 mM N-ethylmaleimide (NEM) and 0.1 mM 
Diethylenetriaminepentaacetic acid (DTPA).  NEM and DTPA were added to prevent the 
interchange between NO metabolites [53]. Cryotubes were immediately placed in a freezer at 
– 80 ˚C, for later analysis of nitrate and nitrite.  1 ml was also extracted from each 70 ml 
beetroot juice ‘shot’ prior to administration, and frozen in untreated opaque cryotubes at – 80 
ºC for subsequent determination of nitrate concentration.   
 
2.5.2. Ozone-based chemiluminescence 
Plasma nitrate and nitrite concentration, and the nitrate content of administered beetroot juice  
were measured by ozone-based chemiluminescence as per the manufacturer’s instructions 
(Sievers NOA 280i, Analytix, UK). Briefly, nitrite was determined by addition of samples to 
0.17M sodium iodide in glacial acetic acid under nitrogen at room temperature. Sodium iodide 
in acetic acid has the capacity to convert nitrite to NO, but is unable to reduce any higher oxides 
of nitrogen such as nitrate and thus is relatively specific for nitrite. To obtain concentration of 
total plasma nitrogen oxides (NOx), we used the same apparatus with a stronger reducing agent 
vanadium chloride (0.1M) in hydrochloric acid (1M) at 95 °C. These stronger conditions reduce 
the sum of all nitrogen oxides, which is predominantly nitrate (μM) but also includes both 
nitrite (nM) and nitrosothiols (nM). Nitrate concentration was calculated by subtraction of the 
nitrite from NOx. 
 
2.6. Statistical analysis 
Data analysis was conducted using SPSS version 22.  An α level of p < 0.05 was accepted for 
significance. Normality was assessed using the Shapiro-Wilk test. Non-normal data was log-
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transformed (log10) prior to analysis.  Physiological data was compared between trials using a 
two-way (time and condition) ANOVA. To adjust for asphericity, the Greinhouse Geisser 
correction was applied for ε < 0.75, and the Huynh-Feldt correction was adopted for ε > 0.75.  
Post-hoc analysis was conducted using t-tests with a Bonferroni adjustment. A paired t-test was 
used to compare TT performance between conditions. The square of Pearson’s correlation 
coefficient (r2) was used to explicate the relationship between variables. A statistical 
spreadsheet was also used to derive a qualitative probabilistic inference for performance data 
[54].  One of the following verbal descriptors was assigned to describe the likelihood of a 
practically beneficial effect of BRJ on performance: < 0.5 %, ‘almost certainly not’; 0.5 – 5 %, 
‘very unlikely not’; 5 – 25 %, ‘unlikely’; 25 – 75 %, ‘possibly’; 75 – 95 %, ‘likely’; ’95-99.5 
%’, ‘very likely’; > 99.5 %, ‘almost certainly’.  Data are presented as means ± SD, unless 
otherwise stated.     
 
3. Results 
3.1. Plasma nitrate and nitrite and exhaled NO 
Plasma nitrate, nitrite and exhaled NO data are presented in Figure 1.  Pre-supplementation 
plasma nitrate concentration was no different between BRJ (28.8 ± 14.3 µmol·L-1) and PLA 
(30.1 ± 29.4 µmol·L-1) (p > 0.05). There was a marked increase in plasma nitrate concentration 
(i.e. a condition effect) in BRJ (493.0 ± 174.4 µmol·L-1) versus PLA (32.5 ± 34.6 µmol·L-1, p 
< 0.01). Significant effects for time (p < 0.001) and time * condition interaction effects (p < 
0.001) were observed. Post-hoc analysis revealed significantly elevated plasma nitrate 
concentration in BRJ compared to PLA and pre-supplementation baseline values, 30 minutes 
post-supplementation, and at all subsequent measurement points (p < 0.001).  Peak plasma 
nitrate concentration occurred on average approximately 2 hours post-supplementation (BRJ = 
594.1 ± 90.5 vs. PLA = 33.9 ± 35.6 µmol·L-1, p < 0.001).  Plasma nitrate concentration was 
unchanged relative to pre-supplementation in PLA (p > 0.05).   
 
Pre-supplementation plasma nitrite concentration did not differ between BRJ (87.5 ± 65.7 
nmol·L-1) and PLA (91.7 ± 70.8 nmol·L-1) (p > 0.05). Conversion of nitrate into nitrite was 
evident, with a significant effect of condition on plasma nitrite concentration (BRJ: 468.0 ± 
252.5 vs. 105.4 ± 57.5 nmol·L-1, p < 0.001). Significant effects for time (p < 0.001) and time * 
condition interaction effects (p < 0.001) were observed. Post-hoc analysis revealed that plasma 
nitrite was significantly greater in BRJ versus PLA and pre-supplementation baseline values, 
1 hour post-supplementation (p < 0.01), and remained higher in BRJ across all subsequent 
measurement points (p < 0.001).   Peak plasma nitrite concentration occurred on average 
approximately 2.5 hours post-supplementation (BRJ = 660.4 ± 265.0 vs. PLA = 109.7 ± 61.0 
nmol·L-1, p < 0.001).  Plasma nitrite concentration was unchanged relative to pre-
supplementation values in PLA (p > 0.05).   
 
Pre-supplementation concentration of exhaled NO was no different between BRJ (32.1 ± 34.7 
p.p.b.) and PLA (36.8 ± 31.5 p.p.b.) (p > 0.05).  There was a significant condition effect on 
exhaled NO (BRJ = 54.1 ± 39.8 vs. PLA = 33.6 ± 31.1 p.p.b., p = 0.002).  Significant effects 
for time (p = 0.021) and time * condition interaction effects (p = 0.002) were observed. Post-
hoc analysis revealed exhaled NO was significantly elevated in BRJ compared with PLA and 
pre-supplementation values at all post-supplementation measurement points (p < 0.05), but 
were unchanged in PLA (p > 0.05).   
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Figure 1 Exhaled NO (A), Plasma nitrite (B) and plasma nitrate (C) throughout experimental trials in the placebo (PLA) (dashed lines) and 
nitrate-rich beetroot juice (BRJ) (solid lines) conditions.  Values are mean ± SEM.  * Time points significantly different between BRJ and 
PLA conditions (p < 0.05). # Time points significantly different from baseline in the BRJ condition.   
 
3.2. Perceived exertion and cardio-respiratory variables 
Data for RPE, HR, MAP, V̇O2, and SaO2 is presented in Table 1.  There was a significant 
condition effect for RPE (BRJ: 13 ± 4 vs. PLA: 14 ± 4, p = 0.037), and a clear effect of time 
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on RPE (p < 0.001), although no time * condition interaction effects were observed (p = 0.152).  
There was a significant time effect on HR (p < 0.001), but no condition (p = 0.495) or time * 
condition interaction effects (p = 0.383) were observed. MAP showed a significant effect of 
condition (BRJ: 83 ± 7 vs. PLA: 86 ± 7 mmHg, p = 0.006), but no time (p = 0.187) or time * 
condition interaction effects (p = 0.646).  There was a significant effect of condition on V̇O2 
(BRJ: 18.4 ± 12.0 vs. 20.4 ± 12.6 ml·kg-1·min-1, p = 0.002).  Likewise, there were significant 
effects of time (p < 0.001) and time * condition interaction effects (p = 0.005) on V̇O2.  Post-
hoc analysis revealed significantly lower V̇O2 in BRJ during exercise at 45 % (p = 0.014) and 
65 % (p = 0.002) V̇O2max.  There was a significant effect of condition (BRJ: 88 ± 3 vs. PLA: 
87 ± 3 %, p < 0.001), time (p < 0.001) and time * condition interaction effects (p = 0.034) on 
SaO2.   Post-hoc analysis revealed significant differences in SaO2 during the pre-exercise rest 
period (p = 0.012) and during exercise at 45 % V̇O2max (p = 0.003). There was no significant 
relationship between the reduction in V̇O2 and increase in SaO2 consequent to BRJ (r2 = 0.13, 
p = 0.242).   
 
Table 1 Ratings of perceived exertion, heart rate, mean arterial blood pressure, oxygen consumption, and arterial oxygen saturation 
throughout experimental trials in the placebo (PLA) and nitrate-rich beetroot juice (BRJ) conditions 
Variable and 
condition 
Arrival Pre-
exposure 
Pre-
exercise 
45 % 
V̇O2max 
65 % 
V̇O2max 
TT 
RPE        
PLA    10 ± 1 12 ± 1 19 ± 1 
BRJa    9 ± 1 12 ± 1 19 ± 1 
 
HR  
(b·min-1) 
      
PLA 61 ± 8 60 ± 9 58 ± 9 107 ± 16 146 ± 13 183 ± 9 
BRJ 58 ± 9 60 ± 8 59 ± 7 105 ± 18 144 ± 12 183 ± 8 
 
MAP 
(mmHg) 
      
PLA 87 ± 8 86 ± 5 85 ± 7   85 ± 10 
BRJa 87 ± 10 81 ± 10 83 ± 7   82 ± 5 
 
VO2  
(ml·kg-1·min-1) 
      
PLA   4.8 ± 1.0 21.4 ± 6.0 33.7 ± 4.3  
BRJa   4.5 ± 0.7 19.2 ± 
5.9b 
31.4 ± 
3.9b 
 
SaO2 
(%) 
      
PLA  98 ± 1 91 ± 3 85 ± 2 81 ± 3 78 ± 7 
BRJa  97 ± 2 94 ± 2b 88 ± 2 b 83 ± 2 80 ± 6 
a denotes significant difference overall (condition effect) versus PLA 
b denotes significant difference (time * condition interaction effect) versus PLA 
 
3.5. TT performance 
BRJ improved 1500 m TT performance by 3.2 % (BRJ = 331.1 ± 45.3 s) versus PLA (341.9 ± 
46.1 s, p < 0.001). Magnitude based inferences [54] indicated that the true value of the effect 
would ‘almost certainly’ be practically beneficial to an athlete. All 12 participants completed 
the TT quicker following BRJ ingestion (Figure 2.), with the range of improvement between 
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1.1 and 20.2 s.  There was no significant correlation between V̇O2max measured at sea-level (r2 
= 0.05; p = 0.48) nor simulated-altitude (r2 = 0.05, p = 0.46) and the change in performance 
following BRJ supplementation.  The observed r2 value indicates that 5 % of the 1500 m TT 
variability can be explained in terms of differences in V̇O2max.  There was no significant 
correlation between the change in VO2 (r
2 = 0.04, p = 0.84) nor SaO2 (r
2 = 0.001, p = 0.90) and 
the change in performance following BRJ.   
 
 
Figure 2 1500 m TT performance following ingestion of placebo (PLA) or nitrate-rich beetroot juice (BRJ). 
 
4. Discussion 
Nitrate-rich beetroot juice has emerged as a popular ergogenic aid, although previous research 
suggests that this supplement has limited effects in well-trained individuals (V̇O2max > 60 
ml·kg-1·min-1).  In contrast, the results of this study suggest that nitrate-rich beetroot juice may 
reduce the O2 cost of exercise, elevate SaO2, and enhance 1500 m TT performance in 
individuals across a range of different fitness levels exercising in moderate-normobaric 
hypoxia.  These data have relevance for the thousands of recreational and competitive athletes 
ascending to altitude each year for sporting purposes.   
 
4.1. Plasma nitrate, nitrite, and exhaled NO 
Consistent with previous investigations, plasma nitrate and nitrite, and exhaled NO 
concentrations were significantly elevated following dietary nitrate supplementation 
[1,2,5,8,55,22,39,38], signifying an increase in the ‘substrates’ available for NO generation via 
the nitrate-nitrite-NO pathway [11].  Peak plasma nitrite concentration was 602 % higher in 
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BRJ versus PLA, similar to Arnold et al. [38] (775 %) (~ 7 mmol nitrate), but considerably 
greater than reported by Muggeridge et al. [22] (134 %) (~ 5 mmol nitrate) and Vanhatalo et 
al. [8] (150 %) (~ 9.3 mmol).  Importantly, all participants increased plasma nitrite 
concentration by substantially greater than 30 % - a cut off proposed by Wilkerson [20] for 
identifying ‘non-responders’. This may, in part, be a consequence of the high nitrate dose 
administered, and may help explain the consistent ergogenic effect observed in this study. 
Nevertheless, there was substantial inter-individual variability in baseline plasma nitrite 
concentration (range: 40 – 300 nmol·L-1), the magnitude of the increase in plasma nitrite 
concentration post-supplementation (∆ range: 160 – 1335 nmol·L-1), and the time at which 
peak plasma nitrite concentration occurred (1 – 3 hours post-supplementation).  A variable 
response to nitrate supplementation has been well-reported in the literature [56].  Inter-
individual differences could not be explained by participant aerobic fitness in this study. 
Genetic factors, chronobiology, variations in the quantity and/or taxa of oral nitrate reducing 
bacteria, and study protocol variables may be important in explaining this phenomenon, and 
require further investigation [56].   
 
4.2. Effect of nitrate supplementation on cardiorespiratory variables and RPE 
In the present study, V̇O2 did not differ significantly between BRJ and PLA during rest in 
hypoxia, but was significantly lower in BRJ versus PLA during steady-state exercise. These 
findings are in line with most previous investigations [4,5,22,37], and similar to the results of 
a recent meta-analysis [6].  The physiological mechanisms underlying the decreased V̇O2 
subsequent to nitrate supplementation have not been fully elucidated, but may be accounted for 
by: a) an improvement in the efficiency of mitochondrial respiration [35] and/or b) enhanced 
efficiency of muscle force production [7].   
 
Larsen and co-workers [35] reported an improvement in the phosphate/O2 (P/O) ratio (i.e. the 
amount of ATP produced per mole O2 consumed) in mitochondria harvested from the vastus 
lateralis of healthy men following three days supplementation with sodium nitrate (0.1 
mmol·kg-1·d-1). This effect was attributed to decreased proton leak during oxidative 
phosphorylation, and was associated with a reduced expression of the ATP/ADP translocase 
protein (ANT) and a tendency towards downregulation of uncoupling protein 3 (UCP3).  The 
change in the mitochondrial P/O ratio correlated with the reduced in vivo V̇O2 measured during 
moderate-intensity cycle ergometry.  In contrast to the findings of Larsen et al. [47] with 
sodium nitrate, a recent investigation by Whitfield and colleagues [57] reported no change in 
mitochondrial efficiency despite a reduced V̇O2, following seven days supplementation with 
nitrate-rich beetroot juice (26 mmol·d-1).  There is presently no explanation as to why sodium 
nitrate and nitrate-rich beetroot juice may have different effects on the mitochondria, and direct 
comparison is therefore warranted to rule out other methodological differences [58]. 
Nevertheless, alterations in mitochondrial efficiency are not necessarily required to explain the 
reduction in V̇O2 reported in this study following BRJ supplementation.   
 
Bailey et al. [7] reported reduced intramuscular PCr, ADP, and Pi perturbations and lower V̇O2 
during leg extension exercise following nitrate-rich beetroot juice supplementation (5.1 
mmol·d-1 x 6 days), reflecting a lower ATP turnover for a given work rate. It was suggested 
that the decreased ATP turnover occurring after nitrate supplementation might be related to a 
reduced ATP requirement for actin-myosin cross-bridge cycling and/or calcium handling, 
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given previous reports that NO slows actin-myosin cross-bridge cycling [59,60] and inhibits 
calcium-ATPase activity [61,62].  Interestingly, a recent murine model investigation reported 
greater force production, and increased expression of the calcium handling protein 
calsoquestrin 1 and the dihydropyridine receptor in type II muscle fibres following nitrate 
supplementation [9].  It was speculated that such effects in humans may allow muscle 
activation at a lower frequency for an equivalent force production, lowering motor unit 
recruitment and concomitantly the ATP cost of exercise.   
 
In the present study, SaO2 was significantly elevated overall in BRJ compared to PLA.  These 
findings are similar to those of Masschelein and colleagues [37] who reported a significant 
increase in SaO2 during cycle ergometry exercise in severe hypoxia (FIO2 11 %) following 6 
days nitrate supplementation (~ 5 mmol·d-1).  Tissue oxygenation in the vastus lateralis was 
also elevated following nitrate supplementation in that study. These findings are supportive of 
the notion that nitrate supplementation may reduce muscle O2 consumption during exercise in 
hypoxia, presumably via the aforementioned mitochondrial [35] and/or muscle [7] alterations 
that also manifest as a reduced V̇O2. Interestingly, Arnold et al. [38] found that runners 
identified as ‘responders’ to nitrate supplementation during a 10,000 m TT in moderate hypoxia 
(FIO2 15.4 %) typically experienced a lower SaO2 during the placebo TT than ‘non-responders’ 
(82 vs 84 %).  This suggests that the SaO2 response to hypoxia may moderate the performance 
effects of nitrate supplementation, possibly due to greater nitrite reduction into NO at lower O2 
tensions [33]. In this study, there was no apparent relationship between average nor post-TT 
SaO2 values and the percentage improvement in performance (r
2 = 0.05).  However, SaO2 
reached lower values in the present investigation (post TT PLA: 77.8 ± 6.9 %) than observed 
by Arnold et al. [38], presumably due to the shorter higher-intensity TT, which may be 
important.     
 
Interestingly, RPE was significantly lower overall in BRJ versus PLA, suggesting reduced 
overall physiological ‘strain’ [52], which may in part be reflective of the lower V̇O2 and/or 
elevated SaO2 with BRJ. In normoxia, Murphy and colleagues [63] reported lower RPE during 
the first mile of a 5 km running TT, although others have reported no effect of nitrate 
supplementation on RPE during sub-maximal and maximal exercise in hypoxia following 
nitrate supplementation [37,38].   
 
4.3. Effect of nitrate supplementation on running performance in hypoxia 
The main finding of the present study was that BRJ improved 1500 m running performance in 
moderate normobaric hypoxia by 3.2 % versus PLA.  Magnitude based inferences suggested 
an ‘almost certain’ chance that the true value of the effect would be practically beneficial. In 
agreement with our hypothesis, there was no apparent relationship between the change in 
exercise performance post-BRJ supplementation and V̇O2max measured in normoxia nor 
hypoxia, suggesting a similar effect of BRJ on TT performance across a range of fitness levels 
under these experimental conditions. 
 
A number of previous investigations have confirmed the beneficial effect of nitrate 
supplementation on TTE [8,24,37] and TT performance [22] in hypoxia.  Conversely, studies 
in well-trained individuals exercising in hypoxia have typically found no effect of nitrate 
supplementation [38–40]. Well-trained individuals exhibit increased presence and activity of 
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the NOS enzymes [31]; possess higher baseline nitrate/nitrite concentration [29]; may 
habitually consume high levels of nitrate as a consequence of their large daily energy intake 
[30]; and experience lower tissue acidosis and hypoxia [20] relative to the untrained.  
Moreover, a recent investigation in normoxia observed an inverse correlation between aerobic 
fitness and the response to nitrate supplementation [17]. It is therefore reasonable to assume 
that adaptations elicited by endurance training may blunt the response to nitrate 
supplementation.    Nevertheless, our results suggest a high training status does not necessarily 
preclude an ergogenic effect of nitrate supplementation.  Instead, it is suggested that individuals 
across a spectrum of aerobic fitness levels may derive similar performance enhancing benefits 
of nitrate supplementation under specific experimental conditions, including a hypoxic 
exercise environment, short-duration high-intensity TT protocol, and high nitrate dose.   
 
Considering generation of NO via the L-arginine NOS pathway is supressed in hypoxia, yet 
the nitrate-nitrite-NO pathway is potentiated as O2 tensions fall [11,33], it is likely that nitrate 
supplementation is more effective in hypoxia than normoxia.  Supportive evidence is provided 
by Kelly et al. [36], who subjected healthy male participants to identical exercise regimes 
preceded by the same nitrate supplement strategy (8.4 mmol·d-1 x 3 days), but with exercise 
varied between normoxia and hypoxia (FIO2 13.1 %).  Nitrate supplementation had no effect 
on severe-intensity cycling TTE in normoxia, but improved TTE by ~ 8.6 % in hypoxia relative 
to placebo.  Further, there is evidence from murine model investigations that nitrate 
supplementation may enhance tissue blood flow [41,42] and muscle contractile function [9] 
preferentially in type II muscle fibres.  It is therefore possible that nitrate supplementation is 
more effective during shorter more high-intensity exercise, during which these muscle fibres 
are more heavily recruited [9,43–45,64], or else in individuals with greater distribution of type 
II muscle fibres [43].  The time-trial duration employed in this study (< 6 minutes) was 
considerably less than other investigations (~ 17 - 48 minutes) which have not observed an 
ergogenic effect of nitrate supplementation in hypoxia [38–40], and may be important. Thus, 
the combination of a hypoxic exercise environment and high-intensity TT may have maximised 
the effects of nitrate supplementation.   
 
Finally, there is some evidence of a dose-response to nitrate supplementation [55,65,66], and 
it is possible that well-trained athletes may require a high nitrate dose to appreciably alter 
plasma nitrite concentration relative to untrained individuals [30].  Therefore, the high nitrate 
dose administered in this study relative to investigations which have not observed an effect of 
nitrate supplementation (~ 5 – 7 mmol) [38–40] may have also contributed towards the 
consistent ergogenic effect observed here.   
 
4.4. Strengths and limitations 
The current study has several strengths.  In particular, the broad spectrum of participant aerobic 
fitness levels allowed us to assess the relationship between V̇O2max and the improvement in 
hypoxic exercise performance following nitrate supplementation.  Nevertheless, none of our 
participants were elite athletes nor entirely sedentary, and it is possible that individuals outside 
of the present fitness range may respond differently to nitrate supplementation.  Moreover, we 
only included healthy male participants, and further research is warranted in other populations 
who may respond differently to nitrate supplementation [67].  A further strength of this 
investigation was that the consumption of nitrate-rich foods was not restricted during the study 
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period.  This approach, first employed by Vanhatalo and colleagues [51] and later adopted in 
several subsequent investigations [25,68], preserves ecological validity and demonstrates that 
nitrate supplementation can alter physiological functioning and exercise performance when 
participants are consuming their normal diet.    
 
4.5. Conclusion 
The present study reported an increase in plasma nitrite concentration, reduction in steady-state 
V̇O2, elevation in SaO2, and enhancement of 1500 m running performance in normobaric 
hypoxia following supplementation with dietary nitrate.  Further, this effect did not appear to 
be related to the aerobic fitness of participants.  This suggests that individuals across a range 
of different aerobic fitness levels may derive a similar performance enhancing benefits of 
dietary nitrate when consuming a high nitrate dose, and conducting moderate and high-intensity 
exercise in a hypoxic environment.   
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